Clinical trial
A Double Blinded, Randomized Trial of Swallowed 1760mcg Fluticasone Propionate Versus Placebo in the Treatment of Eosinophilic Esophagitis
NCT00426283 is registered in ClinicalTrials.gov with Marc Rothenberg, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blinded, Randomized Trial of Swallowed 1760mcg Fluticasone Propionate Versus Placebo in the Treatment of Eosinophilic Esophagitis
- Lead sponsor
- Marc Rothenberg, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- March 31, 2012
- Enrollment
- 42 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.